Mice actually create conditions that copy human illness, for example, cardiovascular ailment, growth and diabetes, different ranges of human diseasesand the ingrained research center mouse has in this way been utilized as a model life form to concentrate acquired human ailments for almost a century.Effective and the extended used of mice models is the present number of updates that have been made in mice models. Biomedical research has gotten a front seat in the human offices and pharmaceutical organizations, to a point where a nation’s propelled work scene can be assessed by its level of significance in biomedical research. Biomedical research can utilize mice models for continuously complex sicknesses, for example, the used of changed mice models for focus the ALS contamination, or the utilization of bleeding edge mice models to fathom lung harm repair.
How Big is the Global Mice Model Market?
The Mice Models Market is expected to be around US$ 1.8 Billion by 2027 at a CAGR of 7.5% in the given forecast period.
The major driving factors of Mice Models Market are as follows:
The restraining factors of Mice Models Market are as follows:
The Mice Models Market is segmented on the lines of its technology, service, type, application, mild care product type and regional. Based on technology segmentation it covers CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, other technologies (Genetically modified sperm-mediated Gene Transfer, Virus/Vector-mediated Gene Transfer, Liposome-mediated DNA & Electroporation of DNA, Biolistics, and TALENs & ZFN). Based on services segmentation it coversbreeding services, cryopreservation, quarantine, rederivation, genetic testing, model in licensing, other services (Surgical, Line Rescue, In Vivo Pharmacology Services). Based on type segmentation it covers inbred mice, genetically engineered mice, conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, spontaneous mutant mice. Based on application segmentation it coversoncology studies, immunology and inflammation studies, diabetes studies, cardiovascular studies, central nervous system studies, other disease studies (Rare Diseases, Renal Disorders, Haematopoiesis, Toxicology, among others). Based on mild care products type segmentation it covers bedding, cages, feed, other care products (Gnotobiotic Equipment, Water Systems, Accessories). The Mice Models Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Mice Models Market and related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for Mice Models Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Mice Models Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Charles River Laboratories International, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), JANVIER LABS (France), Harbour BioMed (China), TRANS GENIC, Inc. (Japan), genOway (France), and Horizon Discovery Group plc (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Mice Models Market has been segmented as below:
By Technology Analysis:
By Services Analysis:
By Type Analysis:
By Application Analysis:
By Mild Care Product Type Analysis:
By Regional Analysis:
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Mice Models Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Mice Models Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
EMEA (Europe, Middle East and Africa) Avian Influenza Vaccines Market
Emergency Contraceptive Pills market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Industry Insights
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.4 Market Forecast Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Mice Model Market: Overview
4.2 Geographic Analysis: Global Mice Care Products Market, By Type
4.3 Global Mice Model Market, By Technology, 2016 vs 2021
4.4 Regional Snapshot of the Global Market For Mice Model
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Ongoing Innovations in Mice Models
5.2.1.1.1 Mice Models for Immune Diseases
5.2.1.1.2 Mice Models for Cancer
5.2.1.1.3 Mice Models for Rare Diseases
5.2.1.2 Growing Consumption of Personalized Medicine Driving the Demand for Humanized Mice Models
5.2.1.3 Continuous Support in the Form of Grants and Investments
5.2.1.4 Growing Number of Pharmaceutical R&D Activities
5.2.1.5 Increasing Focus of Associations on the Development of Embryonic Stem Cells as Well as Knockout and Mutant Mice
5.2.1.5.1 International Mouse Phenotyping Consortium (Impc)
5.2.1.5.2 International Knockout Mouse Consortium (Ikmc)
5.2.2 Restraints
5.2.2.1 Growing Use of Rat Models
5.2.2.2 Increased Benefits From Cryopreservation
5.2.2.3 Regulations and Laws for Ethical Use of Animals in Research
5.2.2.3.1 the Animal Welfare Act
5.2.2.3.2 Public Health Service Policy on Humane Care and Use of Laboratory Animals
5.2.3 Opportunities
5.2.3.1 Emergence of Crispr as A Powerful Tool in the Field of Biomedical Research
5.2.3.2 Rising Demand for Humanized Mice Models
5.2.3.3 Increase in Monoclonal Antibody Production
5.2.4 Challenges
5.2.4.1 Development of Alternative Methods to Animal Testing
5.2.4.2 Advancements in Zebrafish Model Development
5.2.4.3 Growing Need for Improved Mice Models
6 Regulatory Assessment
6.1 Introduction
6.2 North America
6.3 Europe
6.4 China
6.5 Japan
6.6 India
6.7 Australia
6.8 Brazil
7 Clinical Studies Assessment
7.1 Introduction
7.2 Clinical Studies
7.3 Clinical Studies Assessment
8 Mice Model Market, By Type
8.1 Introduction
8.2 Inbred Mice
8.3 Outbred Mice
8.4 Genetically Engineered Mice
8.5 Hybrid/Congenic Mice
8.6 Conditioned/Surgically Modified Mice
8.7 Spontaneous Mutant Mice
9 Mice Model Market, By Service
9.1 Introduction
9.2 Breeding
9.3 Cryopreservation
9.4 Quarantine
9.5 Rederivation
9.6 Model In-Licensing
9.7 Genetic Testing
9.8 Other Services
10 Mice Model Market, By Technology
10.1 Introduction
10.2 Crispr/Cas9
10.3 Microinjection
10.4 Embryonic Stem Cell Injection
10.5 Nuclear Transfer
10.6 Other Technologies
10.6.1 Genetically Modified Sperm-Mediated Gene Transfer
10.6.2 Virus/Vector-Mediated Gene Transfer
10.6.3 Liposome-Mediated DNA and Electroporation of DNA
10.6.4 Biolistics
10.6.5 Talens and Zfns
11 Mice Model Market, By Application
11.1 Introduction
11.2 Oncology Studies
11.2.1 Continuous Grants/Funds Supporting Cancer Research Studies
11.2.2 Agreements & Collaborations Strengthening Cancer Research
11.2.3 Introduction of New Mice Models for Specific Cancers
11.2.4 Expansions Supporting Cancer Research
11.3 Immunology and Inflammation Studies
11.4 Diabetes Studies
11.5 Cardiovascular Studies
11.6 Central Nervous System (Cns) Studies
11.6.1 Grants/Funds Supporting Neurological Research
11.7 Other Disease Studies
12 Mice Care Products Market, By Type
12.1 Introduction
12.2 Cages
12.3 Feed
12.4 Bedding
12.5 Other Care Products
13 Mice Model Market, By Region
13.1 Introduction
13.2 North America
13.2.1 U.S.
13.2.1.1 Increased Focus on Biomedical Research in the U.S.
13.2.1.2 Rise in Monoclonal Antibody Production to Augment the Use of Mice Models
13.2.1.3 Increased Activities By Animal Care Organizations to Create Awareness on Ethical Usage of Animals in Research
13.2.1.4 Development of Biosimilars Boosting the Demand for Preclinical Services
13.2.1.5 Nexus Between Cros and Pharmaceutical Companies: Outsourcing, Partnerships to Aid Market Growth
13.2.2 Canada
13.2.2.1 Growth in Stem Cell Research Activities
13.2.2.2 Government Support for Development of Protein Drugs
13.3 Europe
13.3.1 Germany
13.3.1.1 Launch of Pro-Test Deutschland
13.3.1.2 Growing Biotechnology Industry
13.3.2 U.K.
13.3.2.1 Demand for Statistically Robust Results for Animal Studies
13.3.2.2 Increase in Cell Therapy Preclinical Research
13.3.3 France
13.3.3.1 Funding for Rare Disease Projects in France
13.3.4 Rest of Europe (RoE)
13.3.4.1 Rising Usage of Custom Mice Models in Cancer Research
13.3.4.2 Events Conducted By Animal Care Associations to Promote the Ethical Use of Mice
13.3.4.3 Rising Focus on Rare Disease-Related Research
13.3.4.4 Improving Biomedical Industry in Russia
13.3.4.5 Growth in the Biotech and Pharma Sector of Italy
13.3.4.6 Sweden & Denmark: Growing Investments in Research
13.4 Asia-Pacific
13.4.1 China
13.4.1.1 Rising Focus on Precision Medicine and Personalized Medicine
13.4.1.2 International Alliances for R&D Activities
13.4.1.3 Growing Focus on Pharmaceutical and Mice Model Suppliers
13.4.1.4 Public and Private Investments in China’s Life Sciences Sector
13.4.1.5 Initiatives to Reduce Long Approval Times
13.4.1.6 Intellectual Property (Ip) Breaches, A Challenge for Market Growth
13.4.2 Japan
13.4.2.1 Growth in Biomedical and Medical Research
13.4.2.2 Rising Focus on Life Science Research Activities Like Regenerative Medicine
13.4.3 India
13.4.3.1 Development of Bioclusters to Boost India’s Biotechnology Industry
13.4.3.2 Rising R&D Expenditure, an Indicator of Growth in Research Intensity
13.4.3.3 Shifting of Outsourcing Preclinical Activities From India Towards European Nations
13.4.3.4 Limited Infrastructural Facilities in India
13.4.3.5 Weak Intellectual Property Protection
13.4.4 Rest of Asia-Pacific (RoAPAC)
13.4.4.1 Influx of International Players
13.4.4.2 Ongoing Biomedical Research Activities in Australia
13.4.4.3 Rising Translational and Biomedical Research in SingAPOre
13.4.4.4 Increase in Animal Research in Malaysia
13.4.4.5 Rising Pharmaceutical and Biotechnology R&D in Korea
13.4.5 Rest of the World (RoW)
13.4.5.1 Rising R&D in Brazilian Pharmaceutical, Biotechnology, and Research Industries to Bolster Market Growth
13.4.5.2 Growing Pharmaceutical and Biotechnology Industries in Saudi Arabia and the UAE
14 Mice Model Market: Competitive Landscape
14.1 Overview
14.2 Market Share Analysis (2015)
14.2.1 Charles River Laboratories International, Inc.
14.2.2 The Jackson Laboratory
14.2.3 Taconic Biosciences, Inc.
14.2.4 ENVIGO (Harlan Laboratories, Inc.)
14.3 Competitive Situation and Trends
14.3.1 Alliances, Collaborations, Agreements, Partnerships, and Joint Ventures
14.3.2 Grants & Funds
14.3.3 Expansions
14.3.4 Product Launches
14.3.5 Acquisitions
14.3.6 Licensing
14.3.7 Others
15 Company Profiles
15.1 Introduction
15.2 Charles River Laboratories International, Inc.
15.3 The Jackson Laboratory
15.4 Taconic Biosciences, Inc.
15.5 ENVIGO
15.6 Laboratory Corporation of America Holdings
15.7 Janvier Labs
15.8 Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
15.9 Trans Genic, Inc.
15.10 Genoway
15.11 Horizon Discovery Group PLC (Sage Labs, Inc.)
15.12 Ingenious Targeting Laboratory
The Mice Models Market has been segmented as below:
By Technology Analysis:
By Services Analysis:
By Type Analysis:
By Application Analysis:
By Mild Care Product Type Analysis:
By Regional Analysis:
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
